GT200400136A - 3.5-DISPOSED INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS TO INTERVENE IN OR INHIBIT CELLULAR APPROVALIFERATION. - Google Patents
3.5-DISPOSED INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS TO INTERVENE IN OR INHIBIT CELLULAR APPROVALIFERATION.Info
- Publication number
- GT200400136A GT200400136A GT200400136A GT200400136A GT200400136A GT 200400136 A GT200400136 A GT 200400136A GT 200400136 A GT200400136 A GT 200400136A GT 200400136 A GT200400136 A GT 200400136A GT 200400136 A GT200400136 A GT 200400136A
- Authority
- GT
- Guatemala
- Prior art keywords
- compounds
- intervene
- disposed
- methods
- pharmaceutical compositions
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE DESCRIBEN COMPUESTOS DE INDAZOL 3,5DISUSTITUIDOS QUE MODULAN Y/O INHIBEN LA PROLIFERACION CELULAR TAL COMO LA ACTIVIDAD DE LAS PROTEINAS QUINASAS. ESTOS COMPUESTOS Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN SON CAPACES DE INTERVENIR EN ENFERMEDADES DEPENDIENTES DE LA CDK PARA MODULAR Y/O INHIBIR LA PROLIFERACION CELULARA NO DESEADA. LA INVENCION TAMBIEN SE DIRIGE AL USO TERAPEUTICO O PROFILACTICO DE COMPOSICIONES FARMACEUTICAS QUE CONTIENEN TALES COMPUESTOS Y A METODOS PARA TRATAR EL CANCER ASI COMO OTRAS CONDICIONES PATOLOGICAS ASOCIADAS CON ANGIOGENESIS Y/O PROLIFERACION CELULAR, NO DESEADA, TALES COMO: RETINOPATIA DIABETICA, GLAUCOMA NEOVASCULAR, ARTRITIS REUMATOIDE Y SORIASIS, POR ADMINISTRACION DE CANTIDADES EFICACES DE TALES COMPUESTOS.INDAZOL COMPOUNDS 3.5 DISPOSED THAT MODULATE AND / OR INHIBIT CELLULAR PROLIFERATION SUCH AS THE ACTIVITY OF KINASE PROTEINS. THESE PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS CONTAINING THEM ARE ABLE TO INTERVENE IN DEPENDENT DISEASES OF THE CDK TO MODULATE AND / OR INHIBIT THE UNWANTED CELLULAR PROLIFERATION. THE INVENTION IS ALSO ADDRESSED TO THE THERAPEUTIC OR PROFILACTIC USE OF PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS TO TREAT CANCER AS WELL AS OTHER PATHOLOGICAL CONDITIONS ASSOCIATED WITH ANGIOGENESIS AND / OR PROLIFTIATIMED ROLLAR, DISTRIBUTED CELEBRATION, ASSOCIATED BY NUMBER REUMATOID AND SORIASIS, BY ADMINISTRATION OF EFFECTIVE AMOUNTS OF SUCH COMPOUNDS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49147403P | 2003-07-30 | 2003-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200400136A true GT200400136A (en) | 2005-05-02 |
Family
ID=36947517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200400136A GT200400136A (en) | 2003-07-30 | 2004-07-19 | 3.5-DISPOSED INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS TO INTERVENE IN OR INHIBIT CELLULAR APPROVALIFERATION. |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN1829713A (en) |
GT (1) | GT200400136A (en) |
ZA (1) | ZA200600821B (en) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2011003239A (en) * | 2008-09-26 | 2011-04-28 | Merck Sharp & Dohme | Novel cyclic benzimidazole derivatives useful anti-diabetic agents. |
US8252812B2 (en) | 2009-08-10 | 2012-08-28 | Samumed, Llc | Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof |
CA2770320A1 (en) * | 2009-08-10 | 2011-02-17 | Epitherix, Llc | Indazoles as wnt/b-catenin signaling pathway inhibitors and therapeutic uses thereof |
JP5822844B2 (en) | 2009-12-21 | 2015-11-24 | サミュメッド リミテッド ライアビリティ カンパニー | 1H-pyrazolo [3,4-b] pyridine and therapeutic use thereof |
CN102675286B (en) * | 2011-03-07 | 2015-08-19 | 中国科学院上海药物研究所 | One class indazole compounds and preparation method thereof, purposes and pharmaceutical composition |
EP3473099A1 (en) | 2011-09-14 | 2019-04-24 | Samumed, LLC | Indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors |
PH12017500997A1 (en) | 2012-04-04 | 2018-02-19 | Samumed Llc | Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
AU2013256141B2 (en) | 2012-05-04 | 2016-05-12 | Samumed, Llc | 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
CA2897400A1 (en) | 2013-01-08 | 2014-07-17 | Samumed, Llc | 3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof |
WO2016040180A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof |
WO2016040184A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof |
WO2016040190A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof |
WO2016040185A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof |
WO2016040193A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof |
WO2016040181A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof |
WO2016040182A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine and therapeutic uses thereof |
WO2016040188A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof |
US10285982B2 (en) | 2015-08-03 | 2019-05-14 | Samumed, Llc | 3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof |
WO2017023996A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
WO2017024021A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc | 3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof |
WO2017024025A1 (en) | 2015-08-03 | 2017-02-09 | Sunil Kumar Kc | 3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof |
WO2017023984A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof |
US10231956B2 (en) | 2015-08-03 | 2019-03-19 | Samumed, Llc | 3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
WO2017023989A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof |
US10226448B2 (en) | 2015-08-03 | 2019-03-12 | Samumed, Llc | 3-(1H-pyrrolo[3,2-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof |
WO2017023986A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc | 3-(1h-indol-2-yl)-1h-indazoles and therapeutic uses thereof |
WO2017023975A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof |
US10329309B2 (en) | 2015-08-03 | 2019-06-25 | Samumed, Llc | 3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
US10206909B2 (en) | 2015-08-03 | 2019-02-19 | Samumed, Llc | 3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
US10188634B2 (en) | 2015-08-03 | 2019-01-29 | Samumed, Llc | 3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
US10195185B2 (en) | 2015-08-03 | 2019-02-05 | Samumed, Llc | 3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
US10166218B2 (en) | 2015-08-03 | 2019-01-01 | Samumed, Llc | 3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof |
WO2017023993A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-indol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof |
WO2017024010A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof |
CA3004506A1 (en) | 2015-11-06 | 2017-05-11 | Samumed, Llc | Use of n-(5-(3-(7-(3- fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide in the treatment of osteoarthritis |
CA3026076A1 (en) | 2016-06-01 | 2017-12-07 | Samumed, Llc | Process for preparing n-(5-(3-(7-(3-fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide |
WO2018075858A1 (en) | 2016-10-21 | 2018-04-26 | Samumed, Llc | Methods of using indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors |
JP2019533702A (en) | 2016-11-07 | 2019-11-21 | サミュメッド リミテッド ライアビリティ カンパニー | Single dose adjusted injectable formulation |
-
2004
- 2004-07-19 GT GT200400136A patent/GT200400136A/en unknown
- 2004-07-19 CN CN 200480021613 patent/CN1829713A/en active Pending
-
2006
- 2006-01-27 ZA ZA200600821A patent/ZA200600821B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200600821B (en) | 2007-04-25 |
CN1829713A (en) | 2006-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200400136A (en) | 3.5-DISPOSED INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS TO INTERVENE IN OR INHIBIT CELLULAR APPROVALIFERATION. | |
PA8608201A1 (en) | INDAZOL COMPOUNDS 3,5-DISPOSED, PHARMACEUTICAL COMPOSITIONS AND METHODS TO INTERVENE IN OR INHIBIT THE CELL PROLIFERATION | |
DOP2001000120A (en) | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS OF INDAZOL AND METHODS TO MEASURE AND INHIBIT THE CELL PROLIFERATION | |
GT200100014A (en) | AMIDA COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINASES, AND THEIR INSTRUCTIONS FOR USE. | |
AR023574A1 (en) | TETRACICLIC AZEPININDOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THE USE OF SUCH COMPOUNDS TO PREPARE A MEDICINAL PRODUCT, AND INTERMEDIARIES | |
SV2002000121A (en) | INDAZOL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT THE PROTEIN KINASES AND METHOD FOR USE | |
UY26190A1 (en) | TIAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PROTEINKINASES AND METHODS FOR THEIR USE | |
GT200100061A (en) | PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS AND METHODS TO INHIBIT PROTEIN KINASES. | |
ES2183937T3 (en) | INHIBITORS OF THE CELL ADHESION. | |
UY28213A1 (en) | NEW CYANOPIRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS. | |
PA8592901A1 (en) | INDAZOL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINES, AND PROCEDURES FOR USE | |
PA8493701A1 (en) | COMPOUNDS TO TREAT OBESITY | |
BR9808010B1 (en) | 2-ALKYL-19-NOR-VITAMIN D COMPOUNDS AND PHARMACEUTICAL COMPOSITION UNDERSTANDING THE SAME | |
HN1999000080A (en) | ISOTIAZOL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS. | |
AR026410A1 (en) | '' 2-ARIL-3- (HETEROARIL) -IMIDAZO [1,2-A] SUBSTITUTED PYRIMIDINS, AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS | |
PA8550101A1 (en) | DERIVATIVES OF BENZAMIDA TIAZOL AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT THE PROLIFERATION OF CELLS, AND METHODS FOR USE | |
BR0211559A (en) | Therapeutically useful compounds, tetracyclic binder compositions and their uses | |
UY26877A1 (en) | PIRAZOL-TIAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, AND ITS INSTRUCTIONS FOR INHIBITING CYCLINE-DEPENDENT KINASES | |
MXPA03008635A (en) | Cyano-substituted dihydropyrimidine compounds and their use to treat diseases. | |
UY27232A1 (en) | NEW SUBSTITUTED CYAN DIHYDROPIRIMIDINE COMPOUNDS AND THEIR USE FOR TREATMENT OF MATTERS | |
CL2004000631A1 (en) | COMPOUNDS DERIVED FROM ACID 6- (2-BROMOFENIL) -PIRIDO [2,3-DIPIRIMIDIN-7-CARBOXILICO; PHARMACEUTICAL COMPOSITION; PREPARATION PROCEDURE; AND USE TO TREAT CANCER AND TO PREPARE MEDICATIONS TO INHIBIT TUMOR GROWTH. | |
PA8525701A1 (en) | COMPOUNDS WITH HETEROCICLIC-HYDROXIMINE-FLUORENE NUCLEES AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF KINASE PROTEINS AND METHODS FOR USE | |
DOP2004000953A (en) | INDAZOL COMPOUNDS 3,5-DISPOSED, PHARMACEUTICAL COMPOSITIONS AND METHODS TO INTERVENE IN OR INHIBIT THE CELL PROLIFERATION. | |
CL2004000630A1 (en) | COMPOUNDS DERIVED FROM OXAZOL; SALTS OF SUCH COMPOUNDS; PROCEDURE FOR PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION CONTAINING SUCH COMPOUNDS; AND ITS USE TO INHIBIT TUMOR GROWTH. | |
UY26543A1 (en) | INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MEASURING OR INHIBITING CELL PROLIFERATION. |